CrushSCI.com
98Average days
96Median days
55Fastest days
174Longest days
2952025 publications

Paper Review Records

All Paper Review Records

5 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

60 days

Incidence and Risk Factors of Recurrent Visual Field Progression in Glaucoma

Authors
Davina A. Malek; Douglas R. da Costa; Rafael Scherer; Felipe A. MedeirosShow moreShow less
Affiliations
1. Bascom Palmer Eye Institute, University of Miami, Miami, FloridaShow moreShow less
Official full-text evidence DOI Publisher page
96 days

Safety and Effects of Gildeuretinol Acetate on Retinal Atrophic Lesions in Stargardt Disease

Authors
Christine N. Kay; Leonide Saad; Gabrielle DeBartolomeo; Neil Bressler; Stephen H. Tsang; Kimberly Stepien; Paul Bernstein; Byron L. Lam; Ilyas Washington; Michael B. GorinShow moreShow less
Affiliations
1. Vitreo Retinal Associates, Gainesville, Florida; 2. Alkeus Pharmaceuticals, Cambridge, Massachusetts; 3. Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland; 4. Editor in Chief, JAMA Ophthalmology; 5. Jonas Children’s Vision Care, Edward S. Harkness Eye Institute, Columbia University, New York, New York; 6. Ophthalmology, Medical College of Wisconsin, Milwaukee; 7. Moran Eye Institute, Salt Lake City, Utah; 8. Bascom Palmer Eye Institute, University of Miami, Miami, Florida; 9. Ophthalmology, University of California, Los AngelesShow moreShow less
Official full-text evidence DOI Publisher page
55 days

Ultra–Long-Distance Robotic-Assisted Subretinal Injection for Submacular Hemorrhage

Authors
Andi Xu; Bo Yang; Bingqian Liu; Lin Lu; Zhangkai Lian; Wenben Chen; Rihui Song; Wang Guo; Subinuer Alimu; Zhenzhen Liu; Dong Liu; Yanlin Li; Wei Xiao; Mohammad Ali Nasseri; Kai Huang; Haotian LinShow moreShow less
Affiliations
1. Zhongshan Ophthalmic Center, World Health Organization Collaborating Centre for Eye Care and Vision, State Key Laboratory of Ophthalmology, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Sun Yat-sen University, Guangzhou, China; 2. Department of Ophthalmology, Xinjiang Production and Construction Corps Hospital, Urumqi, China; 3. School of Computer Science and Engineering, Sun Yat-sen University, Guangzhou, China; 4. School of Medicine and Health, Technical University of Munich, Munich, Germany; 5. Hainan Eye Hospital and Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Haikou, China; 6. Department of Genetics and Biomedical Informatics, Institute for Frontier Interdisciplinary Research in Health Sciences and Technology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, ChinaShow moreShow less
Official full-text evidence DOI Publisher page
105 days

Incidence and Risk Factors for Progression of Pachychoroid Subtype

Authors
Yu Jeat Chong; Angie Hon Chi Fong; Wendy Mei Hua Wong; Noa Gilead; Kelvin Yi Chong Teo; Chui Ming Gemmy CheungShow moreShow less
Affiliations
1. Singapore Eye Research Institute, Singapore National Eye Centre, Singapore; 2. Department of Medical Retina, Singapore National Eye Centre, Singapore; 3. Hong Kong Eye Hospital, Hong Kong Special Administrative Region (SAR), China; 4. Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong SAR, China; 5. Department of Ophthalmology, School of Clinical Medicine, The University of Hong Kong, Hong Kong SAR, China; 6. Department of Ophthalmology, National University Hospital, SingaporeShow moreShow less
Official full-text evidence DOI Publisher page
174 days

XXYLT1 and Mendelian Retinal Dystrophy

Authors
Minna Kraatari-Tiri; Hina Ishtiaq; Jaakko Tyrmi; Siying Lin; Andriana Valkama; Timo Tiirikka; Sara Äikäs; Laura Lähteenoja; Genevieve Wright; Elena Schiff; Aleksandr Jestin; Andrew R. Webster; Omar A. Mahroo; Michel Michaelides; Jukka Moilanen; Katri Pylkäs; Johannes Kettunen; Gavin Arno; Aura Falck; Tuomo Mantere; Elisa RahikkalaShow moreShow less
Affiliations
1. Department of Clinical Genetics, Oulu University Hospital, Oulu, Finland; 2. Research Unit of Clinical Medicine and Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland; 3. Center for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland; 4. Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland; 5. Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom; 6. Manchester Centre for Genomic Medicine, Saint Mary’s Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom; 7. National Institute of Health Research Biomedical Research Centre at Moorfields Eye Hospital, London, United Kingdom; 8. University College London Institute of Ophthalmology, University College London, London, United Kingdom; 9. Northern Finland Laboratory Centre Nordlab, Oulu, Finland; 10. Department of Ophthalmology, Oulu University Hospital, Oulu, Finland; 11. Section of Ophthalmology, King’s College London, St Thomas’ Hospital Campus, London, United Kingdom; 12. Biocenter Oulu, University of Oulu, Oulu, Finland; 13. Laboratory of Cancer Genetics and Tumor Biology, Translational Medicine Research Unit, University of Oulu, Oulu, Finland; 14. Greenwood Genetic Center, Greenwood, South Carolina; 15. Department of Genomics, Laboratory Division, Turku University Hospital, Turku, FinlandShow moreShow less
Official full-text evidence DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review62 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at [email protected]

Enter your email address so we can reply. Your details will remain private.